Rapid induction of nuclear transcripts and inhibition of intron decay in response to the polymerase II inhibitor DRB

Journal of Molecular Biology

Volumn 299, Issue 5, 2000, Pages 1179-1191

  Clement, Jade Q ^a   Wilkinson, Miles F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Actinomycin D; DRB; Intron degradation intermediate; Premature transcriptional termination; RNA stability; T cell receptor; Tetracycline

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; DACTINOMYCIN; RNA POLYMERASE II;

ARTICLE; GENETIC TRANSCRIPTION; INTRON; MOLECULAR STABILITY; PRIORITY JOURNAL; RNA METABOLISM; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION;

EID: 0034705339     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.3745     Document Type: Article

References (75)

1. Degradation of mRNA in eukaryotes
2. New proteins related to the Ser-Arg family of splicing factors
3. Regulation of transcriptional elongation by RNA polymerase II
4. Identification and characterization of a nuclease specific for the 3' end of the U6 small nuclear RNA
5. A specific subset of SR proteins shuttles continuously between the nucleus and cytoplasm
6. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro
7. A splicing-dependent regulatory mechanism that detects translation signals
8. Purification of a human polyribosome-associated 3' to 5' exoribonuclease
9. Isolation and characterization of the gene encoding yeast debranching enzyme
10. 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro
11. The stability and fate of a spliced intron from vertebrate cells
12. Requirement of the RNA helicase-like protein PRP22 for release of messenger RNA from spliceosomes
13. A turnover pathway for both stable and unstable mRNAs in yeast: Evidence for a requirement for deadenylation
14. Inhibitors of transcription such as 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole and isoquinoline sulfonamide derivatives (H-8 and H-7) promote dephosphorylation of the carboxyl-terminal domain of RNA polymerase II largest subunit
15. Initiation inhibition and reinitiation of the synthesis of heterogenous nuclear RNA in living cells
16. DRB-induced premature termination of late adenovirus transcription
17. The poly(A) tail inhibits the assembly of a 3'-to-5' exonuclease in an in vitro RNA stability system
18. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
19. Mitotic repression of the transcriptional machinery
20. Transcriptional antitermination
21. A human β-actin expression vector system directs high-level accumulation of antisense transcripts
22. The role of mRNA and protein stability in gene expression
23. RNA polymerase II inhibitor, 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptionai activation of erythroid genes
24. Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases
25. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells
26. RNA splicing and intron turnover are greatly diminished by a mutant yeast branch point
27. Taking a new TAK on Tat transactivation
28. Stability of Drosophila RNA polymerase II elongation complexes in vitro
29. 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole enhances premature termination of late transcription of simian viras 40 DNA
30. Transcriptional activation independent of TFIIH kinase and the RNA polymerase II mediator in vivo
31. TCR mini-gene mRNA expression regulated by nonsense codons: A nuclear-associated translation-like mechanism
32. The Pem homeobox gene: Androgen-dependent and -independent promoters and tissue-specific alternative RNA splicing
33. RNA turnover and the control of mitochondrial gene expression
34. Control of formation of two distinct classes of RNA polymerase II elongation complexes
35. Purification of P-TEFb, a transcription factor required for the transition into productive elongation
36. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase
37. P-TEFb kinase is required for HIV tat transcriptional activation in vivo and in vitro
38. Distinct properties of c-myc transcriptional elongation are revealed in Xenopus oocytes and mammalian cells and by template titration, 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), and promoter mutagenesis
39. The exosome: A conserved eukaryotic RNA processing complex containing multiple 3' → 5' exoribonucleases
40. Premature translational termination triggers mRNA decapping
41. 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription of the beta-hemoglobin gene in vivo at initiation
42. Severe growth H defect in a Schizosaccharomyces pombe mutant defective in intron lariat degradation
43. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation
44. Identification of multiple cyclin sub units of human P-TEFb
45. A spliced intron accumulates as a lariat in the nucleus of T cells
46. T cell receptor-β mRNA splicing during thymic maturation in vivo and in an inducible T cell clone in vitro
47. T cell receptor-β mRNA splicing: Regulation of unusual splicing intermediates
48. Down-regulation of messenger ribonucleic acid (mRNA) for the estrogen receptor (ER) by phorbol ester requires ongoing RNA synthesis but not protein synthesis
49. A protein-binding site in the c-myc promoter functions as a terminator of RNA polymerase II transcription
50. mRNA stability in mammalian cells
51. Ribonucleases involved in eukaryotic mRNA turnover
52. Effect of transcription inhibitors on the iron-dependent degradation of transferrin receptor mRNA
53. Pre-mRNA processing and the CTD of RNA polymerase II: The tail that wags the dog?
54. Definition of subclasses of nucleoplasmic RNA
55. Early termination of heterogenous nuclear RNA transcripts in mammalian cells: Accentuation by 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole
56. Halobenzimidazole ribosides and RNA synthesis of cells and viruses
57. Action of dichlorobenzimidazole riboside on RNA synythesis in L-929 and HeLa cells
58. Ribonuclease E organizes the protein interactions in the Escherichia coli RNA degradosome
59. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs
60. Identification of a 3' → 5' exonuclease activity associated with human RNA polymerase II
61. Interactions of small nuclear RNAs with precursor messenger RNA during in vitro splicing
62. The infranuclear site of excision of each intron in Balbiani ring 3 pre-mRNA is influenced by the time remaining to transcription termination and different excision efficiencies for the various introns
63. Transcription complex stability and chromatin dynamics in wvo
64. Induction of T-cell receptor-alpha and -beta mRNA in SL12 cells can occur by transcriptional and post-transcriptional mechanisms
65. RNA blots: Staining procedures and optimization of conditions
66. Physical isolation of nascent RNA chains transcribed by RNA polymerase II: Evidence for cotranscriptional splicing
67. Interplay between positive land negative elongation factors: Drawing a new view of DRB
68. Transcriptional control: Tat cofactors and transcriptional elongation
69. The transcriptional elongation inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase
70. TFIIH functions in regulating transcriptional elongation by RNA polymerase II in Xenopus oocytes
71. Mechanism of action of dichloro-β-D-ribofuranosylbenzimidazole
72. The transcriptional elongation inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase
73. Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole
74. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages
75. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro